de Filippis, R. and Al Foysal, A. (2024) Case Report: The Role of Monoamine Oxidase Inhibitors in Treating Resistant Depression. Open Access Library Journal, 11, 1-12. doi: 10.4236/oalib.1112369 .

WorkSafe New Zealand is consulting its workforce about a second major restructure plan that would see a net loss of 40 roles, according to unions. The Public Service Association (PSA) said the ...

Newark Liberty International Airport in New Jersey is set to undergo a major revamp ... path forward thanks to this comprehensive vision plan. "As the blueprint shows, we’re ready to take ...

But this year, the U.S. Food and Drug Administration cleared the first app-based treatment for major depressive disorder, which just became available for use this summer. The app, called Rejoyn ...

WASHINGTON, DC August 24, 2022: US President Joe Biden delivers remarks regarding student loan ... [+] forgiveness in the Roosevelt Room of the White House on Wednesday August 24, 2022. Education ...

And while it’s not necessarily a symptom of depression to be sleeping poorly with a newborn, it can make postpartum depression symptoms worse. Without treatment ... help prevent mood disorders. “If I ...

The study tested a treatment called transcranial direct current stimulation (tDCS) to help people with major depressive disorder (MDD). The researchers recruited adults aged 18 or older who were ...

especially treatment-resistant depression. Of the nearly 9 million people with major depression in the United States who have tried pharmaceuticals, 2.8 million are estimated to be resistant to ...

today announced that the Phase 2b study of ALTO-100 in patients with major depressive disorder (MDD) did not meet its primary endpoint, assessed by a change from baseline in Montgomery-Åsberg ...